Johnson Pharmacare share news and announcements
BSE: 532154Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.39.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr3,837th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 Jun 2026
- 49.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −200.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹14 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −150.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −195.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 Jun 2026
- 49.18
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,12,963
Johnson Pharmacare share news and announcements
460 announcements, routine notices left out, newest first. Page 3 of 10.
Jan 2024
8 Jan · Legal
Exchange has sought clarification from Johnson Pharmacare Ltd on January 8, 2024, with reference to Movement in Price. The reply is awaited.
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 1 Nov 2023: quarterly results
Sep 2023
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
May 2023
24 May · Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
18 May · Board meeting
Meeting on 24 May 2023: audited results
Apr 2023
22 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
10 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From April 1, 2022 To March 31, 2023.
Feb 2023
2 Feb · Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jan 2023
27 Jan · Board meeting
Meeting on 2 Feb 2023: quarterly results
Nov 2022
11 Nov · Submission Of Half Yearly Disclosure On Related Party Transactions.
10 Nov · Ref: Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
3 Nov · Board meeting
Meeting on 9 Nov 2022: quarterly results
Oct 2022
10 Oct · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Sep 2022
5 Sep · Reg. 34 (1) Annual Report.
Jul 2022
7 Jul · Board meeting
Meeting on 25 Jul 2022: quarterly results
Jun 2022
7 Jun · Rectification In Submission Of Half Yearly Disclosure On Related Party Transactions.
May 2022
25 May · Submission Of Half Yearly Disclosure On Related Party Transactions.
19 May · Board meeting
Meeting on 25 May 2022: audited results
Apr 2022
15 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015